These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 1286954

  • 1. Leishmania major: bacterial contamination of cutaneous lesions in experimental animals.
    el-On J, Sneier R, Elias E.
    Isr J Med Sci; 1992 Dec; 28(12):847-51. PubMed ID: 1286954
    [Abstract] [Full Text] [Related]

  • 2. Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (Aminosidine) and gentamicin.
    Grogl M, Schuster BG, Ellis WY, Berman JD.
    J Parasitol; 1999 Apr; 85(2):354-9. PubMed ID: 10219319
    [Abstract] [Full Text] [Related]

  • 3. Leishmania major: histopathological responses before and after topical treatment in experimental animals.
    El-On J, Lang E, Kuperman O, Avinoach I.
    Exp Parasitol; 1989 Feb; 68(2):144-54. PubMed ID: 2924878
    [Abstract] [Full Text] [Related]

  • 4. Leishmania major: resistance of promastigotes to paromomycin, and susceptibility of amastigotes to paromomycin-methylbenzethonium chloride ointment.
    el-On J, Sulitzeanu A, Schnur LF.
    Ann Trop Med Parasitol; 1991 Jun; 85(3):323-8. PubMed ID: 1746981
    [Abstract] [Full Text] [Related]

  • 5. Combined topical paromomycin and oral miltefosine treatment of mice experimentally infected with Leishmania (Leishmania) major leads to reduction in both lesion size and systemic parasite burdens.
    Aguiar MG, Silva DL, Nunan FA, Nunan EA, Fernandes AP, Ferreira LA.
    J Antimicrob Chemother; 2009 Dec; 64(6):1234-40. PubMed ID: 19825819
    [Abstract] [Full Text] [Related]

  • 6. Topical treatment of New and Old World cutaneous leishmaniasis in experimental animals.
    el-On J, Hamburger AD.
    Trans R Soc Trop Med Hyg; 1987 Dec; 81(5):734-7. PubMed ID: 3449988
    [Abstract] [Full Text] [Related]

  • 7. Hexadecyl-phosphorylcholine ointment for treatment of cutaneous leishmaniasis: an animal trial.
    Iqbal J, Bukhari I, Jamshid M, Bashir S, Masoom Yasinzai M, Anwar M.
    East Mediterr Health J; 2006 Sep; 12(5):685-9. PubMed ID: 17333810
    [Abstract] [Full Text] [Related]

  • 8. Studies on the topical treatment of experimental cutaneous leishmaniasis: the therapeutic effect of methyl benzethonium chloride and the aminoglycosides, gentamicin and paromomycin.
    Carter KC, Alexander J, Baillie AJ.
    Ann Trop Med Parasitol; 1989 Jun; 83(3):233-9. PubMed ID: 2604461
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis.
    Armijos RX, Weigel MM, Calvopiña M, Mancheno M, Rodriguez R.
    Acta Trop; 2004 Jul; 91(2):153-60. PubMed ID: 15234664
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Transmission blocking vaccine studies in leishmaniasis: II. Effect of immunisation using Leishmania major derived 63 kilodalton glycoprotein, lipophosphoglycan and whole parasite antigens on the course of L. major infection in BALB/c mice.
    Tonui WK, Mbati PA, Anjili CO, Orago AS, Turco SJ, Githure JI, Koech DK.
    East Afr Med J; 2001 Feb; 78(2):90-2. PubMed ID: 11682953
    [Abstract] [Full Text] [Related]

  • 17. Comparison of topical paromomycin sulfate (twice/day) with intralesional meglumine antimoniate for the treatment of cutaneous leishmaniasis caused by L. major.
    Shazad B, Abbaszadeh B, Khamesipour A.
    Eur J Dermatol; 2005 Feb; 15(2):85-7. PubMed ID: 15757817
    [Abstract] [Full Text] [Related]

  • 18. Activity of a paromomycin hydrophilic formulation for topical treatment of infections by Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis.
    Gonçalves GS, Fernandes AP, Souza RC, Cardoso JE, de Oliveira-Silva F, Maciel FC, Rabello A, Ferreira LA.
    Acta Trop; 2005 Feb; 93(2):161-7. PubMed ID: 15652330
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Topical delivery and in vivo antileishmanial activity of paromomycin-loaded liposomes for treatment of cutaneous leishmaniasis.
    Carneiro G, Santos DC, Oliveira MC, Fernandes AP, Ferreira LS, Ramaldes GA, Nunan EA, Ferreira LA.
    J Liposome Res; 2010 Mar; 20(1):16-23. PubMed ID: 19530897
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.